Cookie Notice

This site uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Review our cookies information for more details.

OK

Member Profile

Hans-Uwe Simon, MD, PhD Hans-Uwe Simon, MD, PhD

Institute of Pharmacology, University of Bern, Bern, Switzerland

We are interested in pathogenic mechanisms involved in eosinophilic diseases. Projects range between basic science questions and investigator-driven drug studies. Currently, besides molecular mechanisms of eosinophilia, we are particularly interested in the role of autophagy for eosinophil functions as well as in mechanisms of eosinophil-mediated tissue damage.

Specialty

Apoptosis, autophagy, atopic dermatitis, eosinophils, eosinophilic esophagitis, hypereosinophilic syndrome

Publications

H.-U. Simon, S.G. Plötz, R. Dummer, K. Blaser: Abnormal clones of   T cells producing interleukin 5 in idiopathic eosinophilia. N. Engl. J. Med. 341(1999), 1112-1120.

S. Yousefi, J.A. Gold, N. Andina, J.J. Lee, A.M. Kelly, E. Kozlowski, I. Schmid, A. Straumann, J. Reichenbach, G.J. Gleich, H.-U. Simon: Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat. Med. 14 (2008), 949-953.

A. Straumann, S. Conus, L. Degen, S. Felder, M. Kummer, H. Engel, C. Bussmann, C. Beglinger, A. Schoepfer, H.-U. Simon: Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology 139 (2010), 1526-1537.

D. Simon, S. Hoesli, N. Roth, S. Staedler, S. Yousefi, H.-U. Simon: Eosinophil extracellular DNA traps in skin diseases. J. Allergy Clin. Immunol. 127 (2011), 194-199.